jump to navigation

Shire Receives EMA Approval of Lexington Factory 03/01/2012

Posted by Morse, Barnes-Brown Pendleton in Client News.
Tags: , , ,
trackback

On February 22nd, MBBP client Shire announced that the European Medicines Agency (EMA) has approved the production of its VPRIV enzyme replacement therapies to be made at Shire’s new factory in Lexington, MA. With the additional capacity of a second EMA approved facility, Shire will have the ability to significantly increase the global supply of VPRIV while also providing the company with more manufacturing flexibility.

Please see Shire’s full press release for more information.

Comments»

No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: